Latest Market Research News

Page 3 of 3
Global Masters Fund Limited has appointed long-serving director Jason Pohl as its new Managing Director, signaling continuity in leadership and strategic focus.
Claire Turing
Claire Turing
9 May 2025
Pureprofile Limited has reported a robust Q3 FY25 with revenue up 16% and EBITDA up 16% year-on-year, driving a 20% increase in year-to-date revenue and a 35% jump in EBITDA. The company’s international expansion and new AI-driven solutions underpin its confident outlook for FY25.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Industrial Minerals Ltd has reported promising progress in its high purity quartz beneficiation and ore-sorting trials at the Pippingarra Pegmatite Project, with growing interest from Asian markets and potential new co-products enhancing project economics.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Range International reported a 51% revenue increase in Q1 2025 despite supply chain disruptions that dented cash flow. The company is advancing growth initiatives including pallet rentals in Indonesia and expanding production to the Philippines.
Victor Sage
Victor Sage
29 Apr 2025
Alpha HPA has responded to ASX inquiries confirming the material market sensitivity of its signed Letter of Intent (LOI) and related surge in semiconductor sector sales, underscoring the strategic importance of its high purity materials.
Maxwell Dee
Maxwell Dee
10 Feb 2025
DXN Limited reported a robust 58.1% revenue increase to $4.8 million in Q2 FY25, underpinned by strategic capital raising and new product innovation targeting AI infrastructure. The company is advancing key mining and telecom projects while streamlining operations to support its ambitious $16 million revenue guidance for FY25.
Sophie Babbage
Sophie Babbage
30 Jan 2025
Opyl Limited's Q2 FY25 update reveals robust progress through key partnerships, a new AI Biotech Fund launch, and strengthened financial footing, positioning the company for expanded influence in clinical trial optimisation.
Ada Torres
Ada Torres
29 Jan 2025
Opthea Limited has spotlighted Sozinibercept as a potential game-changer in wet age-related macular degeneration (AMD) therapy, presenting compelling clinical data and a clear path to U.S. market entry.
Victor Sage
Victor Sage
29 Jan 2025
EZZ Life Science Holdings delivered a robust Q2 FY25 with a 16.6% increase in customer receipts and a 308% jump in operating cash flows, while gearing up for US market entry and expanding its global footprint.
Victor Sage
Victor Sage
23 Jan 2025